Triple Point Biologics entered the industry of Research and Development Laboratories in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541712, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact by calling (503) 222-5527 during business hours. You can also write to the business’ Single Location at 2611 Sw 3rd Avenue, Portland, Oregon OR 97201. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Triple Point Biologics |
| Place of Business: | 2611 Sw 3rd Avenue, Portland, OR 97201 |
| Contact Number: | (503) 222-5527 |
| Type of Service: | Research and Development Laboratories |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2011 |
| Income/Year: | $50.000 to $99.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Triple Point Biologics is a company operating from Multnomah, Oregon providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2011 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 541712 as Research and Development Laboratories.
With a current employee count of 1 to 4, Triple Point Biologics has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative at (503) 222-5527 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 2611 Sw 3rd Avenue in Portland, Oregon 97201 and can be engaged online through the company website at , the company Twitter , and Facebook page .